Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Jnj crawled time : 12:15 save search
Iveric Bio Reports Third Quarter 2021 Operational Highlights and Financial Results
Published: 2021-11-09 (Crawled : 12:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
ISEE | $39.95 0.38% 0.38% 0
|
Health Technology
|
| O: -2.11%
H: 0.0%
C: 0.0%
financial results results
Global Cerebrospinal Fluid Drainage Catheter Market (2021 to 2027) - by Application, Type and Regional Outlook
Published: 2021-11-05 (Crawled : 12:15) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
NTUS | $32.96 0.09% 0.0%
|
Health Technology
|
| O: 5.85%
H: 8.15%
C: 7.02%
IART | $28.68 -9.33% -10.29% 2.9M
|
Health Technology
|
| O: -0.71%
H: 2.56%
C: 1.12%
application
New Analyses Suggest Favorable Results for STELARA® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn's Disease and Ulcerative Colitis
Published: 2021-10-25 (Crawled : 12:15) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.32%
H: 0.36%
C: 0.22%
disease therapy results ulcerative colitis
Multiple Corporate Partners Come On Board To Support Movember
Published: 2021-10-20 (Crawled : 12:15) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.07%
H: 0.47%
C: -0.12%
Locus Biosciences Secures Financing of up to $25 Million from Hercules CapitalProceeds to be used to advance development of synthetic biology engine and manufacturing capabilities
Published: 2021-10-19 (Crawled : 12:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.49%
H: 2.64%
C: 1.85%
HTGC F | $18.46 1.15% 0.38% 660K
|
Finance
|
| O: 0.06%
H: 0.58%
C: 0.35%
Janssen Submits Application Seeking U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
Published: 2021-10-08 (Crawled : 12:15) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
treatment fda fda approval approval application
Arrowhead Earns $10 Million Phase 1 Milestone Payment
Published: 2021-09-28 (Crawled : 12:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.5%
C: -0.18%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: -6.56%
phase 1 phase 2 phase 3 milestone
PM360 Magazine Announces Winners of 2021 Trailblazer Awards
Published: 2021-09-24 (Crawled : 12:15) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
awards
New Test Shows If Your COVID Vaccine is Still Protecting You, Buy Online from Epitome Risk
Published: 2021-09-21 (Crawled : 12:15) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.71%
H: 0.83%
C: -0.05%
covid risk test vaccine
Mirati Therapeutics Appoints David Meek as Chief Executive Officer
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: 0.0%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: -2.68%
H: 4.17%
C: 2.46%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.78%
H: 11.36%
C: 3.1%
ETTX | $2.19 -0.46% 0.46%
|
Health Technology
|
| O: -0.64%
H: 25.56%
C: 11.65%
therapeutics
With Market Size Valued at $7.7 Billion by 2026, it`s a Healthy Outlook for the Global Medicated Skin Care Products Market
Published: 2021-09-15 (Crawled : 12:15) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.12%
H: 0.58%
C: 0.25%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.28%
H: 0.2%
C: -0.1%
skin
Global $1.15 BN Medical Electrodes(Reusable/Disposable) Markets to 2025 - Emerging Countries Offer Lucrative Opportunities
Published: 2021-08-27 (Crawled : 12:15) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.27%
H: 0.24%
C: 0.06%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 0.34%
H: 0.84%
C: 0.6%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
CNMD | $72.64 2.2% 0.0% 500K
|
Health Technology
|
| O: 0.54%
H: 1.81%
C: 1.28%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: 0.35%
H: 0.34%
C: -0.48%
NTUS | $32.96 0.09% 0.0%
|
Health Technology
|
| O: 0.77%
H: 2.4%
C: 1.68%
CNMD | $72.64 2.2% -1.98% 500K
|
Health Technology
|
| O: 0.54%
H: 1.81%
C: 1.28%
Lynk Pharmaceuticals announced the completion of Series B financing of $50 million
Published: 2021-08-27 (Crawled : 12:15) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
Global Patient Centric Healthcare App Market to Generate $385,767.5 Million and Exhibit a CAGR of 34.9% from 2020 to 2027 - Exclusive Report [240 pages] by Research Dive
Published: 2021-08-27 (Crawled : 12:15) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
CSCO | $48.33 0.46% 0.46% 20M
|
Technology Services
|
| O: 0.11%
H: 0.0%
C: 0.0%
research
Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine
Published: 2021-08-25 (Crawled : 12:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.17%
H: 0.12%
C: -0.83%
covid vaccine covid-19
Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs
Published: 2021-08-17 (Crawled : 12:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.3%
H: 1.24%
C: 1.22%
integration trial commercialization
Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002
Published: 2021-08-12 (Crawled : 12:15) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.01%
H: 0.85%
C: 0.79%
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
Published: 2021-08-05 (Crawled : 12:15) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -0.09%
LUMO | $2.57 -1.91% -1.95% 12K
|
Health Technology
|
| O: 0.0%
H: 1.73%
C: 0.93%
financial results results pharma
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant
Published: 2021-08-02 (Crawled : 12:15) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.02%
H: 0.21%
C: -0.12%
ENLV | $1.4 -4.23% 110K
|
Health Technology
|
| O: 2.83%
H: 19.92%
C: 11.4%
PLX | $1.15 1.77% -2.61% 450K
|
Health Services
|
| O: 0.65%
H: 2.6%
C: 2.6%
biotech iot chmp designation
HC2 Holdings Provides $15 Million Series C Investment to Portfolio Company R2 Technologies
Published: 2021-07-21 (Crawled : 12:15) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.5%
H: 0.23%
C: 0.11%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.